600867.SS
Price:
$8.81
Market Cap:
$17.22B
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.
Industry
Drug Manufacturers - General
IPO Date
1994-08-24
Stock Exchange
SHH
Ticker
600867.SS
According to Tonghua Dongbao Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.50B. This represents a change of 8.68% compared to the average of 15.19B of the last 4 quarters.
The mean historical Enterprise Value of Tonghua Dongbao Pharmaceutical Co., Ltd. over the last ten years is 24.22B. The current 16.50B Enterprise Value has changed 6.71% with respect to the historical average. Over the past ten years (40 quarters), 600867.SS's Enterprise Value was at its highest in in the June 2018 quarter at 57.93B. The Enterprise Value was at its lowest in in the March 2025 quarter at 13.91B.
Average
24.22B
Median
25.57B
Minimum
17.31B
Maximum
32.86B
Discovering the peaks and valleys of Tonghua Dongbao Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.70%
Maximum Annual Enterprise Value = 32.86B
Minimum Annual Increase = -19.66%
Minimum Annual Enterprise Value = 17.31B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 17.33B | -15.40% |
| 2023 | 20.48B | 18.36% |
| 2022 | 17.31B | -19.66% |
| 2021 | 21.54B | -18.58% |
| 2020 | 26.46B | 4.12% |
| 2019 | 25.41B | -10.08% |
| 2018 | 28.26B | -14.00% |
| 2017 | 32.86B | 27.68% |
| 2016 | 25.74B | -4.13% |
| 2015 | 26.85B | 77.70% |
The current Enterprise Value of Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.37B
5-year avg
20.62B
10-year avg
24.22B
Tonghua Dongbao Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (14.85B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.90B), less than Apeloa Pharmaceutical Co.,Ltd (17.95B), less than Yifan Pharmaceutical Co., Ltd. (17.04B), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.36B), less than Andon Health Co., Ltd. (20.61B), greater than Beijing Aosaikang Pharmaceutical Co., Ltd. (14.52B), greater than Anhui Anke Biotechnology (Group) Co., Ltd. (16.15B), greater than Qingdao Baheal Medical Inc. (13.53B), greater than Zhejiang CONBA Pharmaceutical Co.,Ltd. (11.70B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 14.85B | $15.89B | |
| 13.90B | $16.28B | |
| 17.95B | $18.50B | |
| 17.04B | $15.40B | |
| 18.36B | $19.37B | |
| 20.61B | $18.99B | |
| 14.52B | $15.85B | |
| 16.15B | $16.29B | |
| 13.53B | $11.91B | |
| 11.70B | $11.92B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonghua Dongbao Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tonghua Dongbao Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tonghua Dongbao Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?
What is the 3-year average Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?
What is the 5-year average Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?
How does the current Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) compare to its historical average?